UCLA’s AI flagged about 80% of missed early Alzheimer’s cases while aiming to reduce racial gaps in diagnosis.
Researchers at UCLA are harnessing the power of artificial intelligence to help identify who's at risk of Alzheimer's disease ...
Researchers at Los Angeles-based UCLA Health have developed an AI model that uses EHRs to identify patients with undiagnosed Alzheimer’s disease. The model was trained on records from more than 97,000 ...
Alzheimer’s disease touches millions of families across the United States and remains the most common neurodegenerative disorder in older adults. More than six million Americans currently live with ...
Hosted on MSN
Alzheimer's disease digital resources lacking for Latinos, Hispanics in Los Angeles years after COVID-19, study finds
Although Latinos and Hispanics are at elevated risk for Alzheimer's disease and account for almost half of Los Angeles County's population, a recent UCLA Health study finds that accessible digital ...
FOX 13 Tampa Bay on MSN
Research shows that hormone replacement therapy can help reduce brain inflammation, diseases
Research out of UCLA links brain inflammation to diseases such as Alzheimer's and multiple sclerosis.
A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
Ramat Gan, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results